The Obstetrics and Gynecology Hospital of Fudan University, commonly known as the Red House Hospital, is a teaching hospital in Shanghai, China, affiliated with the Shanghai Medical College of Fudan University. It is rated Grade 3, Class A, the highest rating in the Chinese medical system.

There are 820 beds in Obstetrics & Gynecology Hospital of Fudan University.

During the past decade, Obstetrics & Gynecology Hospital of Fudan University conducted 48 clinical trials. In the 10-year time frame, 48 clinical trials started and 1 clinical trials were completed, i.e. on average, 2.1% percent of trials that started reached the finish line to date. In the past 5 years, 30 clinical trials started and 1 clinical trials were completed. i.e. 3.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Obstetrics & Gynecology Hospital of Fudan University" #1 sponsor was "Fudan University" with 16 trials, followed by "Xiaojun Chen" with 6 trials sponsored, "Obstetrics & Gynecology Hospital of Fudan University" with 4 trials sponsored, "Chia Tai Tianqing Pharmaceutical Group Co., Ltd." with 2 trials sponsored and "Children's Hospital of Fudan University" with 2 trials sponsored. Other sponsors include 21 different institutions and companies that sponsored additional 27 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Obstetrics & Gynecology Hospital of Fudan University" #1 collaborator was "Obstetrics & Gynecology Hospital of Fudan University" with 7 trials as a collaborator, "Children's Hospital of Fudan University" with 4 trials as a collaborator, "Peking University Third Hospital" with 3 trials as a collaborator, "Tongji Hospital" with 3 trials as a collaborator and "West China Second University Hospital" with 3 trials as a collaborator. Other collaborators include 108 different institutions and companies that were collaborators in the rest 94 trials.

According to Clinical.Site data, the most researched conditions in "Obstetrics & Gynecology Hospital of Fudan University" are "Atypical Endometrial Hyperplasia" (6 trials), "Endometrial Neoplasms" (3 trials), "Fertility Issues" (3 trials), "Ovarian Cancer" (3 trials) and "Advanced Endometrial Cancer" (2 trials). Many other conditions were trialed in "Obstetrics & Gynecology Hospital of Fudan University" in a lesser frequency.

Most popular intervention types in "Obstetrics & Gynecology Hospital of Fudan University" are "Drug" (37 trials), "Procedure" (6 trials), "Device" (5 trials), "Other" (4 trials) and "Biological" (3 trials). Other intervention types were less common.

The name of intervention was led by "Megestrol Acetate" (5 trials), "Paclitaxel" (3 trials), "placebo" (3 trials), "Carboplatin" (2 trials) and "Intensive Lifestyle Intervention (ILI)" (2 trials). Other intervention names were less common.

The vast majority of trials in "Obstetrics & Gynecology Hospital of Fudan University" are 50 trials for "Female" genders and 6 trials for "All" genders.

Currently, there are NaN active trials in "Obstetrics & Gynecology Hospital of Fudan University". 1 are not yet recruiting, 22 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Obstetrics & Gynecology Hospital of Fudan University, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Obstetrics & Gynecology Hospital of Fudan University, 3 "Phase 1" clinical trials were conducted, 19 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 10 trials that are defined as “Not Applicable".

Obstetrics & Gynecology Hospital of Fudan University has several departments that took part in Clinical trials: "Shanghai Ji Ai Genetics & IVF Institute, Obstetrics and Gynecology Hospital of Fudan University" - 3 trials